Semaglutide was linked to greater weight loss and a 15% lower fracture risk in people with type 2 diabetes, raising the possibility of an unexpected bone health benefit. People with type 2 diabetes who took semaglutide experienced greater weight loss and a lower risk of bone fractures than those using several other weight-loss medications, according [...]

Medicines that help people lose weight have transformed the treatment of obesity in just a few years. Many people who struggled with weight for decades are now losing amounts of weight that were previously difficult to achieve without surgery. Among the most widely used treatments are a group of medicines called GLP-1 drugs. These medicines […]

The post Which Weight-Loss Drug Works Best? appeared first on Knowridge Science Report.

People taking popular GLP-1 weight-loss drugs like Ozempic, Wegovy, Mounjaro, and Zepbound may be shedding pounds, but a new study suggests they are also moving less. People with obesity who lost weight while taking popular medications such as Ozempic, Wegovy, Zepbound, and similar drugs became significantly less physically active, according to research presented at ENDO [...]

Weight-loss medicines such as semaglutide and tirzepatide have become some of the most talked-about drugs in the world. Their brand names, including Ozempic, Wegovy, Rybelsus, Mounjaro, and Zepbound, are now familiar to millions of people. They are often described as breakthrough treatments because many patients have achieved weight loss that was previously difficult to reach […]

The post Why Some People Lose a Lot of Weight on Ozempic and Mounjaro While Others Hardly Lose Any appeared first on Knowridge Science Report.